Home

Niklas Boknäs

Presentation

Publications

2024

Abigail S. McGovern, Pia Larsson, Volga Tarlac, Natasha Setiabakti, Leila Shabani Mashcool, Justin R. Hamilton, Niklas Boknäs, Juan Nunez-Iglesias (2024) Finding and following: a deep learning-based pipeline for tracking platelets during thrombus formation in vivo and ex vivo Platelets, Vol. 35, Article 2344512 (Article in journal) Continue to DOI

2023

Kjersti Tunströmer, Lars Faxälv, Pia Larsson, Tomas Lindahl, Niklas Boknäs (2023) Thrombus remodelling by reversible and irreversible P2Y(12) inhibitors Platelets, Vol. 34, Article 2157805 (Article in journal) Continue to DOI

2022

P. Larsson, V Tarlac, T-Y Wang, T. Bonnard, C. E. Hagemeyer, J. R. Hamilton, R. L. Medcalf, S. H. Cody, Niklas Boknäs (2022) Scanning laser-induced endothelial injury: a standardized and reproducible thrombosis model for intravital microscopy Scientific Reports, Vol. 12, Article 3955 (Article in journal) Continue to DOI
Niklas Boknäs, Cia Laine, Andreas Hillarp, Ankit Macwan, Kerstin Gustafsson, Tomas Lindahl, Margareta Holmström (2022) Associations between hemostatic markers and mortality in COVID-19-Compounding effects of D-dimer, antithrombin and PAP complex Thrombosis Research, Vol. 213, p. 97-104 (Article in journal) Continue to DOI

2021

Mikael Lund, Ankit Macwan, Kjersti Tunströmer, Tomas Lindahl, Niklas Boknäs (2021) Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses Frontiers in Cardiovascular Medicine, Vol. 8, Article 717835 (Article in journal) Continue to DOI

Research

blood droplet in red microscope light

Haemostasis Research Group in Linköping

We study regulation of platelet activation and interaction with coagulation from biochemistry and genes to clinical studies on antithrombotic drugs in cardiovascular diseases and how covid-19 causes thrombosis. We also develop new diagnostic methods.

Tags